Comparison of LED and Conventional Fluorescence Microscopy for Detection of Acid Fast Bacilli in a Low-Incidence Setting

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
PLoS ONE (Impact Factor: 3.53). 07/2011; 6(7):e22495. DOI: 10.1371/journal.pone.0022495
Source: PubMed

ABSTRACT Light emitting diode fluorescence microscopes have many practical advantages over conventional mercury vapour fluorescence microscopes, which would make them the preferred choice for laboratories in both low- and high-resource settings, provided performance is equivalent.
In a nested case-control study, we compared diagnostic accuracy and time required to read slides with the Zeiss PrimoStar iLED, LW Scientific Lumin, and a conventional fluorescence microscope (Leica DMLS). Mycobacterial culture was used as the reference standard, and subgroup analysis by specimen source and organism isolated were performed.
There was no difference in sensitivity or specificity between the three microscopes, and agreement was high for all comparisons and subgroups. The Lumin and the conventional fluorescence microscope were equivalent with respect to time required to read smears, but the Zeiss iLED was significantly time saving compared to both.
Light emitting diode microscopy should be considered by all tuberculosis diagnostic laboratories, including those in high income countries, as a replacement for conventional fluorescence microscopes. Our findings provide support to the recent World Health Organization policy recommending that conventional fluorescence microscopy be replaced by light emitting diode microscopy using auramine staining in all settings where fluorescence microscopy is currently used.


Available from: Christina Greenaway, May 17, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: SUMMARY: Rapid, affordable and accurate tuberculosis (TB) diagnosis is key to effective patient management and global TB control. Effective clinical screening and optimised sample acquisition methods remain the first steps in the diagnostic process. Smear microscopy, despite optimisation, remains widely used even though its sensitivity is poor. Mycobacterial liquid culture is accurate but poorly accessible. The use of novel molecular tools, such as Xpert1 MTB/RIF (Cepheid, Sunnyvale, CA, USA) or GenoType1 MTBDRplus (Hain Lifescience GmbH, Nehren, Germany) assays, which offer superior diagnostic accuracy and decreased time-to-diagnosis for drug- sensitive and/or -resistant TB, is increasing following World Health Organization (WHO) endorsement and, in some countries, national roll-out is underway. In contrast, both serology (antibody-detection tests) and interferon-><c release assays (IGRAs) have been found to offer little diagnostic utility for active TB diagnosis and have been discouraged by WHO. IGRAs and the tuberculin skin test (TST) remain important tools for latent TB infection (LTBI) diagnosis, with numerous guidelines available, although recent studies have highlighted their limitations in predicting progression to active disease. Other novel, simple technologies, such as the point-of-care (POC) urine lipoarabinomannan strip test and the visually read loop isothermal amplification PCR nucleic acid amplification technique (NAAT), although of uncertain and restricted clinical utility, highlight the progression toward an inexpensive, instrument-free, laboratory-free POC diagnostic technology for TB in the future.
    European Respiratory Monograph, 2012 01/2012: chapter 10; , ISBN: 1025-448x
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bacteriological diagnosis of tuberculosis has benefited in recent years from many technological advances to improve rapidity and sensitivity of the techniques. Thus, new LED fluorescence microscopes are in the process of replacing the optical microscopes and the Ziehl-Neelsen technique, making the examination more precise, faster and easier. The manual and automatic liquid culture has improved Lowenstein-Jensen culture and helped shorten antibiotic sensitivity test, allowing appropriate management of patients. The development and standardization of molecular biology methods led to the rapid detection and identification of mycobacterium directly in clinical samples but also of resistance genes for early diagnosis of MDR-TB and dealing with them quickly. However, the performance of these techniques does not sufficiently cover the diagnosis of smear-negative tuberculosis, extrapulmonary forms, children- and immune-compromised tuberculosis where sensitivity is limited. The diagnosis of latent tuberculosis is reinforced by the in vitro release testing of gamma interferon overcoming the lack of specificity of the tuberculin skin test. Despite considerable progress, more amelioration is still needed to improve these techniques in order to extend them to the paucibacillary tuberculosis and to facilitate their access to low-resource countries. Copyright © 2015 Elsevier Masson SAS. All rights reserved.
    Revue de Pneumologie Clinique 03/2015; DOI:10.1016/j.pneumo.2015.02.002 · 0.19 Impact Factor